09-24-2009, 03:57 PM
This HIV study has interesting ethical elements as well as rather earth-shaking ramifications. Two snippets I found very relevant are copied below.
Cheers,
~Frag :w00t:
Quote:The study actually tested a two-vaccine combo in a "prime-boost" approach, where the first one primes the immune system to attack HIV and the second one strengthens the response.That was how, these are the numbers:
They are ALVAC, from Sanofi Pasteur, the vaccine division of French drugmaker Sanofi-Aventis; and AIDSVAX, originally developed by VaxGen Inc. and now held by Global Solutions for Infectious Diseases, a nonprofit founded by some former VaxGen employees.
ALVAC uses canarypox, a bird virus altered so it can't cause human disease, to ferry synthetic versions of three HIV genes into the body. AIDSVAX contains a genetically engineered version of a protein on HIV's surface. The vaccines are not made from whole virus â dead or alive â and cannot cause HIV.
Quote:Results: New infections occurred in 51 of the 8,197 given vaccine and in 74 of the 8,198 who received dummy shots. That worked out to a 31 percent lower risk of infection for the vaccine group.Here's to hoping the research is used to further a true vaccine as well as a possible cure, and that it's somehow avaiable to everyone that has it.
The vaccine had no effect on levels of HIV in the blood of those who did become infected. That had been another goal of the study â seeing whether the vaccine could limit damage to the immune system and help keep infected people from developing full-blown AIDS.
That result is "one of the most important and intriguing findings of this trial," Fauci said. It suggests that the signs scientists have been using to gauge whether a vaccine was actually giving protection may not be valid.
"It is conceivable that we haven't even identified yet" what really shows immunity, which is both "important and humbling" after decades of vaccine research, Fauci said.
Cheers,
~Frag :w00t:
Hardcore Diablo 1/2/3/4 & Retail/Classic WoW adventurer.